← Insider buys
ALXN

Alexion Pharmaceuticals, Inc.

EVP and Chief Compliance Officer Indrani Lall Franchini sold $174K of Alexion Pharmaceuticals, Inc.

Sold$173,765
$118.53Price
1,466Shares
−4%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Fri, Jun 8. Filed Tue, Jun 12, 12:52 PM ET, during the session. Not investment advice.